Pillstats
Rx only · Injection, Powder, Lyophilized, For Solution · Intravenous

Tobramycin

Tobramycin Sulfate

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)10627
US makers6 labelers
Packages8
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1182373554742025 Q12025 Q22025 Q32025 Q42026 Q1
281
Rx · 2026 Q1
4.6K
Units dispensed
-32%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
XGen Pharmaceuticals DJB, Inc.unknown2SUPPLYING
Xiromed, LLC.unknown2SUPPLYING
Fosun Pharma USA Incunknown1SUPPLYING
NorthStar Rx LLCunknown1SUPPLYING
Eugia US LLCunknown1SUPPLYING
Gland Pharma Limitedunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Feb 22, 2024
    RECALLRecall (Class II): Tobramycin for Injection, USP, 1.2 grams per Pharmacy Bulk Package, Rx Only, For Intravenous Use, PHARMACY BULK PACKAGE…

    Failed Stability Specification: Water determination was found not complying with specification. — Recalling firm: Eugia US LLC — Nationwide